GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (OTCPK:ANTCF) » Definitions » Current Deferred Revenue

ANTCF (Aion Therapeutic) Current Deferred Revenue : $0.15 Mil (As of Jan. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Aion Therapeutic Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Aion Therapeutic's current deferred revenue for the quarter that ended in Jan. 2025 was $0.15 Mil.

Aion Therapeutic Current Deferred Revenue Historical Data

The historical data trend for Aion Therapeutic's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aion Therapeutic Current Deferred Revenue Chart

Aion Therapeutic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Current Deferred Revenue
Get a 7-Day Free Trial - - - - -

Aion Therapeutic Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.40 0.15

Aion Therapeutic Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Aion Therapeutic's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Aion Therapeutic Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (OTCPK:ANTCF) » Definitions » Current Deferred Revenue
Comparable Companies
XCNQ:RIPP XCNQ:AYUR XCNQ:HERB XCNQ:FFNT XCNQ:CVGR TSXV:DHB XCNQ:BBM XCNQ:XBRA NEOE:TILT XCNQ:IMCC ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
AION:Canada
Address
700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8
Website
https://www.aiontherapeutic.com
Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery. During the year ended the Company had one operating segment, being health and wellness, dedicated to delivering state-of-the-art water filtration solutions. Geographically company earns revenue from USA.